Share Name Share Symbol Market Type Share ISIN Share Description
GlaxoSmithKline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +18.20p +1.40% 1,318.60p 1,319.00p 1,319.20p 1,322.20p 1,302.80p 1,309.00p 9,801,955 16:35:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 30,186.0 3,525.0 31.4 42.0 65,378.76

GlaxoSmithKline PLC Director/PDMR Shareholding

15/01/2018 5:34pm

UK Regulatory (RNS & others)


GlaxoSmithKline (LSE:GSK)
Historical Stock Chart

2 Months : From Dec 2017 to Feb 2018

Click Here for more GlaxoSmithKline Charts.

TIDMGSK

RNS Number : 9373B

GlaxoSmithKline PLC

15 January 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Ms E Walmsley 
===  ======================  ================================= 
 b)   Position/status        Chief Executive Officer 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    473.274 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ======================================================== 
 a)   Name                   Mr R G Connor 
===  ======================  ================================ 
 b)   Position/status        President, Global Manufacturing 
                              & Supply 
===  ======================  ================================ 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================ 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ======================================================== 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================ 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================ 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================== 
 a)   Description            Ordinary shares of 25 pence each 
       of the financial       ('Ordinary Shares') 
       instrument             ISIN: GB0009252882 
===  ======================  ================================ 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================ 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    82.400 
                               ------------  ---------- 
===  ======================  ================================ 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================ 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================ 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================ 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr L Debruyne 
===  ======================  ================================= 
 b)   Position/status        President, Global Vaccines 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    851.563 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr S Dingemans 
===  ======================  ================================= 
 b)   Position/status        Chief Financial Officer 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    919.518 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr D S Redfern 
===  ======================  ================================= 
 b)   Position/status        Chief Strategy Officer 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    1552.174 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Ms C Thomas 
===  ======================  ================================= 
 b)   Position/status        SVP, HR 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    599.748 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mr P C Thomson 
===  ======================  ================================= 
 b)   Position/status        President, Global Affairs 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    728.198 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Dr P J T Vallance 
===  ======================  ================================= 
 b)   Position/status        President, R&D 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    2918.217 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 
 
 1.   Details of PDMR/person closely associated 
       with them ('PCA') 
===  ========================================================= 
 a)   Name                   Mrs K Thomson 
===  ======================  ================================= 
 b)   Position/status        PCA of Mr P C Thomson (President, 
                              Global Affairs) 
===  ======================  ================================= 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ================================= 
 2.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
===  ========================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ================================= 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ================================= 
 3.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================= 
 a)   Description             Ordinary shares of 25 pence each 
       of the financial        ('Ordinary Shares') 
       instrument              ISIN: GB0009252882 
===  ======================  ================================= 
 b)   Nature of              Acquisition of Ordinary Shares 
       the transaction        following the re-investment of 
                              dividends paid to shareholders 
                              on 11 January 2018. 
===  ======================  ================================= 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)               ------------  ---------- 
                                GBP13.3440    137.540 
                               ------------  ---------- 
===  ======================  ================================= 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ================================= 
 e)   Date of the            2018-01-11 
       transaction 
===  ======================  ================================= 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ================================= 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDELFFVFFXBBF

(END) Dow Jones Newswires

January 15, 2018 12:34 ET (17:34 GMT)

1 Year GlaxoSmithKline Chart

1 Year GlaxoSmithKline Chart

1 Month GlaxoSmithKline Chart

1 Month GlaxoSmithKline Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20180218 08:27:11